MoneyWorks4Me

Laurus Labs signs agreement with MPP

21 Jan 2022 Evaluate

Laurus Labs has signed an agreement with MPP (Medicine Patient Pool). The agreement is for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..